Private Equity Dentistry: Top Firms in 2026

Key Facts

• Over 130 PE-backed dental groups operate in North America as of 2025, with industry estimates suggesting closer to 200 active dental service organizations backed by private equity firms.
• The DSO market reached approximately $139 billion in 2024 and is forecast to grow at a 17%-18% compound annual growth rate through 2030, reaching $454 billion to $761 billion.
• Dental care generated 161 PE deals in 2024, the highest transaction count of any single healthcare category, up 10.3% from 2023.
• PE affiliation among dentists nearly doubled from 6.6% in 2015 to 12.8% in 2021, with oral surgeons, endodontists, orthodontists, and pediatric dentists each more than doubling their affiliation rates over that period.
• EBITDA multiples for dental practice acquisitions range from 4x to 8x, and large, highly profitable practices can command 100%-150% of annual revenue.
• The largest 2025 transaction in North American dentistry was GTCR's C$2.2 billion take-private of Dentalcorp, Canada's largest dental group with 575+ clinics, at a 33% premium.
• PE investors owned 27 of the top 30 DSOs as of 2021, making institutional capital the dominant ownership structure among large dental groups.

The Dental PE Market: Scale, Structure, and Growth

Private equity discovered dentistry because of one structural feature: extreme fragmentation. Dental practice in the United States has historically operated as a cottage industry, with tens of thousands of independent owner-operators. That fragmentation created a textbook consolidation opportunity for buyout funds seeking to aggregate cash-flow-positive businesses at predictable EBITDA multiples.

The Dental Service Organization (DSO) is the vehicle enabling this consolidation. Under the DSO model, a PE-backed management company acquires the non-clinical, administrative operations of dental practices: billing, HR, marketing, procurement, and technology. In most states, licensed dentists must legally own their practices under corporate practice of dentistry (CPOD) laws. PE firms work within those restrictions through long-term management services agreements between a licensed dentist-owned professional corporation and the DSO entity.

Six states (Arizona, Mississippi, North Dakota, New Mexico, Ohio, and Utah) permit direct PE ownership of dental practices, simplifying deal structures for platforms operating there. Dallas-Irving, Texas, has emerged as the leading geographic hub for DSO headquarters, hosting MB2 Dental, U.S. Oral Surgery Management, and Specialized Dental Partners. Nashville, the New York metro area, and Sarasota round out the key operating centers.

PE deployed an estimated $4.4 billion into dental between 2011 and 2019. Deal velocity has accelerated sharply since, with 161 transactions completed in 2024 alone.

Dental Private Equity: Firm Comparison

The table below covers the primary PE sponsors active in dentistry and their flagship dental portfolios. AUM data for individual PE firms in this sector is not publicly disclosed; the comparison emphasizes portfolio scale, strategy, and sector strength instead.

The largest platforms by practice count belong to KKR's Heartland Dental and Leonard Green's Aspen Dental, representing over 2,700 affiliated practices combined. Mid-market sponsors such as Shore Capital and Great Hill Partners have built differentiated positions in specialty subsectors where procedure reimbursements are structurally higher than in general dentistry.

Top Picks by Investment Strategy

Largest Platform Builder: KKR (Heartland Dental). Heartland's 1,700+ affiliated practices make it the single largest DSO by practice count, setting the benchmark for general dentistry consolidation at institutional scale.

Specialty Oral Surgery Leader: Oak Hill Capital (U.S. Oral Surgery Management). Operating across 27 states with four additional practice add-ons completed in August 2025 alone, USOSM is the broadest-reach oral and maxillofacial surgery platform in the sector.

Strongest Dual-Platform Track Record: Harvest Partners. The only top-tier dental PE sponsor managing two large general dentistry platforms simultaneously, Harvest holds both Affordable Care (400+ practices) and Dental Care Alliance (390+ practices), acquired alongside Mubadala Investment Company in January 2023.

Top Pediatric Investor: Great Hill Partners (Blue Cloud Pediatric Surgery Centers). The 2025 majority investment in Blue Cloud's 32-location outpatient anesthesia surgery network is the most specialized pediatric dental transaction of the year.

Most Active in Specialty Roll-Ups: Shore Capital Partners. Running Southern Orthodontic Partners, Great Lakes Dental Partners, and Innovate 32 simultaneously, Shore is the clearest mid-market multi-specialty aggregator. Southern Orthodontic Partners added TC Orthodontics (seven Minneapolis offices) in August 2025.

Growth Equity Leader in Pediatric Dentistry: GarMark Partners (SALT Dental Partners). Its 2025 growth investment into SALT's 153-practice pediatric network reflects accelerating capital flow into Medicaid-heavy pediatric platforms.

Cross-Border Consolidator: GTCR (Dentalcorp). The C$2.2 billion take-private of Canada's largest dental group in September 2025 at a 33% premium demonstrates the willingness of US buyout funds to pursue continental dental acquisitions.

Top Dental PE Firms and DSO Platforms in Detail

KKR and Heartland Dental

Heartland Dental is the reference point for scale in dental PE: 1,700+ affiliated practices make it the largest DSO in the United States by practice count, and KKR provides the institutional backing. For general dentists considering DSO affiliation, Heartland offers the most mature operational infrastructure in the sector, with centralized billing, HR, procurement, and scheduling systems built through years of add-on acquisitions.

The practical implication for joining dentists is a standardized operating environment with limited room for practice-specific customization. KKR brings deep capital markets expertise, but Heartland's size means dentists become one of many hundreds of affiliated providers. They join a mature institution rather than a growing platform with potential equity upside for early participants.

Charlesbank Capital Partners and MB2 Dental

MB2 Dental's defining feature is its non-captive structure, which distinguishes it from most PE-backed DSOs. Boston-based Charlesbank Capital Partners, a mid-market buyout fund, took a controlling interest in MB2's 500-practice platform in 2021. MB2 operates under a joint venture model in which dentists retain equity ownership in their individual practices while contracting with the DSO for administrative support.

This structure appeals to owners seeking partnership rather than a full sale. Headquartered in Dallas, MB2 has built one of the most geographically diversified mid-market platforms in the sector. Its model contrasts directly with pure buyout platforms where dentists transition to W-2 employees after the workback period ends.

Harvest Partners and the Dual-Platform Strategy

Harvest Partners is the only top-tier dental PE sponsor managing two large general dentistry platforms simultaneously, reflecting deliberate sector conviction rather than opportunistic deal flow. Affordable Care, with 400+ practices headquartered in Morrisville, NC, joined the portfolio in 2021. Dental Care Alliance, with 390+ practices based in Sarasota, FL, came through a joint acquisition with Mubadala Investment Company, the Abu Dhabi sovereign wealth fund, in January 2023.

That co-investment with a Gulf sovereign fund illustrates how leading dental PE platforms have attracted international limited partners seeking US healthcare exposure. For dentists evaluating Harvest-backed platforms, the sponsor's track record of running multiple large platforms through full investment cycles provides meaningful precedent on secondary sale dynamics.

Oak Hill Capital and U.S. Oral Surgery Management

Oral and maxillofacial surgery attracts disproportionate PE capital because procedure reimbursements run significantly higher than in general dentistry, generating the EBITDA margins that buyout funds require. Oak Hill Capital's U.S. Oral Surgery Management (USOSM), headquartered in Irving, TX, operates across 27 states and completed four additional oral surgery practice acquisitions in August 2025.

Oak Hill chose a single high-reimbursement specialty and built the national platform within it, rather than pursuing general dentistry breadth. Oral surgeons considering USOSM affiliation encounter the deepest specialty network in the country, backed by a fund manager with a focused oral surgery investment thesis.

Shore Capital Partners and the Multi-Specialty Model

Shore Capital Partners runs the broadest multi-specialty dental portfolio of any mid-market PE firm, building positions across orthodontics and general dentistry from its Chicago base. The fund backs Southern Orthodontic Partners, Great Lakes Dental Partners, and Innovate 32, three distinct platforms spanning different dental segments. Southern Orthodontic Partners added TC Orthodontics (seven offices in Minneapolis) in August 2025, illustrating Shore's active add-on acquisition pace.

Shore operates at a fund size substantially below the mega-buyout firms, yet has built meaningful platform density across multiple specialty categories. Specialists considering Shore-backed platforms encounter a sponsor with direct management attention at the portfolio company level, a material difference from institutional-scale DSOs where individual practice performance may receive less sponsor visibility.

GTCR and Dentalcorp

GTCR's September 2025 acquisition of Dentalcorp for C$2.2 billion is the landmark dental PE transaction of the year. Dentalcorp is Canada's largest dental group, with 575+ clinics, and the take-private gives GTCR a continental platform extending beyond the increasingly saturated US general dentistry market. The deal closed at a 33% premium to the pre-announcement share price.

GTCR also backs 7to7 Dental within the United States, indicating a deliberate multi-platform dental strategy. Canadian dentists affiliated with Dentalcorp post-closing face the same secondary sale dynamics familiar to US DSO-affiliated dentists: a fund manager with a 3-7 year hold horizon and a clear expectation of a secondary sale or recapitalization at the conclusion of that period.

Great Hill Partners and Blue Cloud Pediatric Surgery Centers

Blue Cloud Pediatric Surgery Centers serves children and special needs patients requiring sedation or general anesthesia for dental procedures, a subsector with structurally limited competition and high procedure complexity. Great Hill Partners, a Boston-based growth equity fund, took majority control of Blue Cloud's 32-location, 13-state outpatient surgery network in August 2025. Blue Cloud is headquartered in The Woodlands, TX, with facility-level reimbursements substantially exceeding traditional chairside dental fees.

Great Hill's focus on a high-barrier specialty rather than competing in crowded general dentistry illustrates the broader PE capital rotation toward higher-acuity dental subsectors. Pediatric dental specialists evaluating this platform encounter an investor with a clear subspecialty thesis and fresh capital committed for continued expansion.

Investment Trends Shaping the DSO Market

Specialty Consolidation Accelerating Beyond General Dentistry

The first wave of dental PE focused on general practice roll-ups; the current wave is predominantly specialty-driven. PE affiliation more than doubled between 2015 and 2021 among oral surgeons, endodontists, orthodontists, and pediatric dentists. Oral and maxillofacial surgery now supports multiple competing national platforms, including U.S. Oral Surgery Management (27 states), Beacon Oral Specialists (90+ practices, 11 states, backed by Blue Sea Capital), and MAX Surgical Specialty Management (practices in five states, backed by MedEquity Capital).

Endodontic-only platforms such as Endodontic Practice Partners (Nashville, RC Capital) and U.S. Endodontics Partners represent the most focused expression of this specialty segmentation trend.

Secondary PE-to-PE Sales Are the Primary Exit Mechanism

Fund managers typically hold dental platform investments for 3-7 years before transitioning to a new buyer, and secondary sales known as "second bite" transactions have become the dominant exit path. Dentists who rolled equity into a platform at formation receive a second liquidity event when the initial fund sells to a new PE buyer. New buyers typically require dentists to retain a rollover equity percentage for alignment and often introduce equity incentive programs for junior dentists to maintain engagement.

For dentists affiliated with a first-generation PE platform, the secondary sale timeline is a critical planning variable. The income repair concept (restoring post-acquisition compensation toward pre-sale levels) depends on where in the hold period the dentist joined relative to when EBITDA growth materializes.

Pediatric Dentistry and Outpatient Surgery Centers Attract Growth Capital

Pediatric dentistry's Medicaid-heavy patient base attracted fresh institutional capital decisively in 2025. GarMark Partners invested in SALT Dental Partners (153 practices), Great Hill Partners took majority control of Blue Cloud's 32-location outpatient surgery network, and both Chord Specialty Dental Partners and BeBright completed pediatric practice add-on acquisitions in August 2025 alone. Outpatient dental surgery centers for children requiring general anesthesia represent the highest-acuity end of the trend, with facility-level reimbursements substantially exceeding traditional chairside dental fees.

Technology Standardization and AI-Driven Operations

PE-backed DSOs are deploying centralized technology stacks, including AI-assisted scheduling, automated revenue cycle management, and standardized electronic health records across affiliated practices. Reducing billing errors and optimizing appointment density across hundreds of locations generates measurable EBITDA improvement at the platform level. A 2025 peer-reviewed study found that PE-owned dental offices shifted their treatment mix toward higher-cost restorative and surgical procedures post-acquisition, with submitted charges increasing 3.3%, though provider reimbursements remained flat and additional costs were passed to patients.

Rising Dental School Debt Sustains DSO Associate Pipelines

The average dental graduate in 2024 carries over $300,000 in student loan debt, creating structural pressure toward DSO employment over capital-intensive practice ownership. Associates who cannot service traditional practice acquisition debt become a reliable talent pipeline for PE-backed platforms seeking to staff acquired locations. This dynamic gives DSOs meaningful leverage in compensation negotiations that independent practices cannot easily offset through continuing education stipends or partnership tracks alone.

How to Evaluate Dental PE Firms

Track record in healthcare is a necessary but insufficient starting criterion. The more important filter is the specific PE sponsor's history within dentistry: how many platforms have they exited, what did the secondary sale outcomes look like, and did affiliated dentists receive their full workback payments. Sponsors who entered the dental sector recently with a single platform have no dental-specific track record to compare against competitors with multiple realized exits.

EBITDA multiple offers require independent verification before acceptance. EBITDA normalization adjusts for owner compensation, one-time expenses, and forward-looking cost assumptions, and each sponsor calculates it differently. The management fee (typically 5%-15% of revenue) charged post-closing reduces effective yield below the headline acquisition multiple. Dentists should retain a dental business attorney to independently calculate EBITDA and model the post-closing economics before accepting any valuation proposal.

Clinical autonomy provisions vary significantly across DSO structures. Joint venture models typically preserve more clinical decision-making authority than full affiliation agreements. The scope of the management services agreement determines how much operational control the DSO exercises over scheduling, materials, staffing, and treatment protocols.

The workback period (usually three years) and the profitability targets attached to the deferred 30% payment are the two contract clauses where dentists most frequently report post-signing regret. Staff benefit changes (particularly healthcare premiums and retirement plan contribution limits) are frequently underweighted during due diligence. They become a major retention issue when existing team members face reduced benefits after closing.

For limited partners evaluating dental PE funds, compliance posture and clinical quality metrics should carry weight alongside financial return projections. The 2018 DOJ settlement with Benevis/Kool Smiles for $24 million over Medicaid fraud and unnecessary procedures on children represents the clearest precedent of how regulatory enforcement risk can materially impair a dental PE investment. Assessing whether a fund-backed DSO has faced state attorney general inquiries, antitrust reviews, or Medicaid audit findings is a non-negotiable component of institutional due diligence in this sector.

Which Firm Fits Your Needs?

Dentists approaching retirement with established practices generating strong production are the most competitive sellers in today's dental PE market. KKR's Heartland Dental and Charlesbank's MB2 Dental both operate at the scale to absorb such practices efficiently, but the two represent meaningfully different propositions. Heartland is a standardized institutional environment; MB2's joint venture model preserves co-ownership.

Dentists who prioritize a second liquidity event should evaluate Harvest Partners' platforms directly. Harvest has executed multiple large-scale general dentistry secondary transactions, and its dentist-affiliated partners have specific precedent for what the "second bite" process entails.

Specialists have a wider field of purpose-built platforms to consider. Oral surgeons should evaluate Oak Hill's U.S. Oral Surgery Management, Blue Sea Capital's Beacon Oral Specialists, and MedEquity Capital's MAX Surgical. All three offer oral surgery-only operating environments that general-dentistry DSOs cannot replicate clinically. Pediatric dentists with practices in active acquisition markets should look at GarMark's SALT Dental Partners and InTandem Capital's BeBright, both of which received fresh institutional growth capital in 2025 and are in active add-on acquisition mode.

LPs building diversified healthcare alternatives portfolios should note three data points: dental PE generated 161 transactions in 2024 (the highest count of any healthcare category), the sector projects a 17%-18% CAGR through 2030, and GTCR's Dentalcorp acquisition at a 33% premium has validated exit pricing at scale. Sponsors running multi-platform dental strategies (Harvest Partners, Shore Capital) offer within-sector diversification that single-platform funds cannot provide.

Methodology

This guide to private equity in dentistry covers the PE-backed DSO landscape using publicly reported transaction data, healthcare industry research, and dental M&A advisory analyses through 2025. Platform practice counts represent the most recently disclosed figures from public announcements and industry reports. Because AUM data for individual PE sponsors active in dental is not publicly disclosed, firm comparisons emphasize portfolio scale, deal history, and investment strategy rather than fund size. EBITDA multiple ranges are sourced from dental M&A advisory publications and legal analyses of DSO transaction structures, primarily through 2023. Regulatory and clinical quality data draws on peer-reviewed healthcare research, federal enforcement records, and investigative journalism findings. This article does not constitute legal, financial, or M&A advisory guidance; dentists and LPs evaluating specific transactions should engage qualified legal and financial advisors before executing any agreement.